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1. Introduction
The group of anaerobic Gram-negative cocci 
(AGNC) includes the genera Veillonella, Mega-
sphaera, Anaeroglobus, Negativicoccus and Acidami-
nococcus [1]. These bacteria (with Veillonella species 
in the highest numbers among the members of 
the group) are an integral part of the microbiome 
of the oral cavity and the gastrointestinal, genito-
urinary and respiratory tracts of humans [1,2]. Be-
fore the advent of molecular methods (polymerase 
chain reaction) and novel diagnostic techniques 
in the clinical microbiology laboratories (e.g., 
mass spectrometry, sequencing), identification of 
anaerobic Gram-negative cocci was based solely 
on Gram stain morphology and anaerobic cultiva-
tion [2-5]. Awareness regarding the roles of anaer-
obes in various infectious diseases has increased 
in recent years, especially due to the pronounced 
interest towards the study of the human microbi-
ome; although the organisms mostly studied were 
Clostridium, Bacteroides, Prevotella, Fusobacterium 
species and Gram-positive anaerobic cocci (GPAC) 
[6-8]. There is a distinct lack of data and an uncer-
tainty regarding the prevalence and importance 
of AGNC species in human infections: these or-
ganisms are recovered in pure culture relatively 
infrequently, in addition, many laboratories do 
not have the suitable resources and equipment 
(e.g., GasPack jars, anaerobic glove boxes) for their 
isolation and identification [9,10]. The epidemiolo-
gy of different pathogens shows great variation 
among time periods and geographic regions 
therefore, the assessment of local data is essential 
to evaluate trends over time and to reflect on the 
national situation, compared to international 
data. The aim of this study was to assess and 
compare the prevalence of different species of 
AGNCs among inpatients and outpatients at the 
Albert Szent-Györgyi Clinical Center (Szeged, 
Hungary) retrospectively, during a 10-year study 
period.
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2. Materials and methods
2.1. Study design
The Albert Szent-Györgyi Clinical Center is an 
1,820-bed (1,465 active and 355 chronic beds, respec-
tively), primary and tertiary care university-affiliat-
ed (University of Szeged) teaching hospital, servic-
ing an urban and rural population in the southeast 
region of Hungary of about 405,000 people. 
Isolates containing AGNC were identified retro-
spectively by reviewing the online microbiology re-
cords of the Institute of Clinical Microbiology. The 
data screening included samples taken at inpatient 
departments and outpatient clinics over a 10-year 
period (January 2008–December 2017). In addition, 
patient data was also collected, limited to demo-
graphic characteristics (age, sex, inpatient/outpa-
tient status) and sample type. Isolates were consid-
ered separate if they occurred more than 30 days 
apart or different AGNCs were isolated [11,12].
2.2. Identification of isolates
The processing of samples arriving to the Institute 
of Clinical Microbiology was carried out according 
to guidelines in routine clinical bacteriology. The 
cultivation of anaerobic bacteria was carried out in 
line with principles in anaerobic bacteriology, at 
37°C in an anaerobic chamber (Baker Ruskinn, 
York, UK). Between 2008 and 2012, the identification 
of anaerobic isolates was carried out based the pre-
sumptive methods recommended by the Wad-
sworth Anaerobic Bacteriology Manual, additional-
ly, with the Rapid ID 32A (bioMérieux, Marcy-
l’Étoile, France) identification kit [13]. From 2013 on-
wards, identification was performed using matrix-
assisted laser desorption/ionization time-of-flight 
mass spectrometry (MALDI-TOF MS). Bacterial 
cells were transferred to a stainless-steel target us-
ing a sterile toothpick. An on-target extraction was 
performed by adding 1 ml of 70% formic acid prior 
to the matrix. After drying at ambient temperature, 
the cells were covered with 1 ml matrix HCCA (a-
cyano-4-hydroxycinnamic acid in 50% acetoni-
trile/2.5% trifluoro-acetic acid). Mass spectrometry 
measurements were performed by the Microflex 
MALDI Biotyper (Bruker Daltonics, Bremen, Ger-
many) in positive linear mode across the m/z range 
of 2 to 20 kDa; for each spectrum, 240 laser shots at 
60 Hz in groups of 40 shots per sampling area were 
collected [5]. The MALDI Biotyper RTC 3.1 software 
(Bruker Daltonics, Bremen, Germany) and the 
MALDI Biotyper Library 3.1 were used for spec-
trum analysis. Antibiotic susceptibility testing is 
not routinely performed from AGNC isolates [14,15].
2.3. Statistical analyses
Descriptive statistical analysis (including means 
or medians with ranges and percentages to char-
acterize data) was performed using Microsoft Ex-
cel 2013. Additional statistical analyses were per-
formed with SPSS software version 24 (IBM SPSS 
Statistics for Windows 24.0, Armonk, NY, IBM 
Corp.), using the χ2-test and Mann-Whitney’s 
U-test to compare groups. P values below 0.05 
were considered statistically significant.
3. Results and discussion
3.1. Study population
The median age of affected patients overall was 52 
years (range: 1–90 years), with a male dominance 
(56.64%, with male-to-female ratio of 1.31), which 
was present is most of the individual study years 
(Table I). 59.79% of samples originated from inpa-
Table I General characteristics of the study population (grouped by study year)
Study year 2008 2009 2010 2011 2012
No. of affected patients 19 29 27 21 39
Male-to-female ratio 2.17 1.23 0.80 1.33 0.74
Percentage of inpatients 57.89% 68.97% 48.15% 61.90% 58.97%
Median age [yrs] 55 50 47 56 52
Age range [yrs] (1-75) (6-87) (3-79) (18-90) (2-84)
 
Study year 2013 2014 2015 2016 2017
No. of affected patients 30 44 68 134 159
Male-to-female ratio 1.00 2.33 1.34 0.56 1.26
Percentage of inpatients 63.33% 65.00% 69.12% 63.43% 52.20%
Median age [yrs] 54 55 55 49 51
Age range [yrs] (11-83) (4-84) (1-86) (8-81) (7-83)
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tients. No statistically significant difference was 
observed between the patient characteristics (gen-
der, age, inpatient/outpatient status; p>0.05), how-
ever, a slight dominance of patients ≥50 years of 
age could be noted in both the inpatient and out-
patient groups (58.48% for inpatients and 63.63% 
for outpatients, respectively). 
Almost one-third of the samples originated 
from the Department of Otorhinolaryngology 
(29.29%); other major contributors to positive sam-
ples include the Departments of Surgery (16.07%), 
Internal Medicine 11.61%) and Oral Surgery 
(10.89%), while the remaining 32.14% of samples 
originated from nine other institutions (Table II).
31.45% of isolated GNACs originated from ab-
scess samples, while various wound isolates ob-
tained by invasive sampling methods (19.82%) or 
superficial swabbing (15.64%) were also prevalent. 
Other positive samples include bile specimens, 
puncture samples from the sinuses and inner ear, 
bronchoalveolar lavage, blood cultures and intra-
uterine devices (IUD) (33.09%). The composition of 
sample types that were positive for AGNCs is not 
surprising as most of these originated from ana-
tomical regions, where these bacteria as present as 
normal flora, in addition to being relevant patho-
gens, if there is an underlying pathology or surgi-
cal intervention in the patient’s anamnestic data.
During the 10-year study period, 572 individual 
AGNCs isolates were recovered from clinical sam-
ples at the Albert Szent-Györgyi Clinical Center. 
Most of the isolated GNACs were Veillonella spp. 
(95.28%), including V. parvula and V. atypica (corre-
sponding to more than half of the isolated species) 
as the most frequently isolated genera during the 
study period; in contrast, Megasphaera and Acidami-
nococcus species accounted for only a minority of 
isolates (2.79% and 1.93%, respectively), while An-
aeroglobus and Negativicoccus species were not iso-
lated (Table III). AGNCs were isolated as stand-
alone pathogens in only 32.87% of cases, they were 
mostly isolated together with other bacteria, as part 
of a complex aerobic/anaerobic flora. The number 
of isolated AGNCs was significantly higher in the 
period after 2013 (136 vs. 436 isolates; p<0.001). In 
the first half of the study period (2008-2012), most 
of the isolated pathogens were identified only at a 
genus level (78.83%), while in the second half of the 
study period (2013-2017), 91.31% of isolates were 
identified on the species level (p<0.001). 
4. Conclusions
The current study represents a long-term surveil-
lance study on the isolation frequency and trends 
among anaerobic Gram-negative cocci (AGNCs), 
isolated in the Southern Great Plain of Hungary 
over a 10-year period. To the best of our knowl-
edge, this is the first and longest-spanning study 
reporting on their prevalence (and infections 
caused by these pathogens by proxy) in Hungary. 
Based on the results of this retrospective survey, 
the most prevalent isolates at our tertiary-care cen-
ter were Veillonella spp. (which may be considered 
the anaerobic counterparts of Neisseria species), 
while other species in the group only represented 
a fraction of the isolated species; this is in line with 
the findings of the few studies available in the lit-
erature. Hospitalization, a slight male dominance 
and the age (>50 years) of many affected patients 
also correspond to literature findings [1-3,5,10]. 
There was a significant increase in both the num-
ber of isolated AGNC species and their correct 
(species-level) identification in the second half of 
the study period. Both may be explained by the in-
troduction of the MALDI-TOF MS identification 
system to the diagnostic workflow of the laborato-
Table II Origin of samples of interest at the Albert Szent-
Györgyi Clinical Center (SZTE)
Department/Clinic %
ENT 29.29
Surgery 16.07
Internal Medicine 11.61
Oral Surgery 10.89
Neurology   0.71
Obstetrics and Gynecology   3.21
Pediatrics   3.93
Dermatology   8.93
Intensive care   5.71
Emergency   1.61
Ophtalmology   0.36
Traumatology   5.71
Urology   1.96
ENT: Dept. of Otorhinolaryngology
Table III Species distribution among GNACs in the study 
period (2008-2017)
Veillonella spp.  545  (95.28%)
V. parvula  238  (41.60%)
V. atypica  103  (18.01%)
V. dispar  56  (9.79%)
V. denticariosi  5  (0.87%)
V. ratti  2  (0.35%)
Megasphaera spp.  16  (2.79%)
Megasphera muciniformis  10  (1.75%)
Acidaminococcus spp.  11  (1.93%)
Acidaminococcus intestinum  8  (1.39%)
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ry. Several studies have reported on the beneficial 
changed MALDI-TOF put forth in clinical micro-
biology, both in regard to the speed and the quali-
ty of identification [16]. This is especially true with 
anaerobic bacteria, as their cultivation and identi-
fication with conventional methods is time- and 
resource-consuming [5,9].
If we analyse these results from a clinical per-
spective, this would mean that 1-2 positive samples 
were received by the Institute of Clinical Microbiol-
ogy per week, where significant growth of AGNCs 
was detected. In these cases, the continuous com-
munication between physicians and the diagnostic 
microbiology laboratory is crucial. The role of the 
laboratory is to supply clinically relevant informa-
tion in a precise and timely manner, which should 
be reciprocated by the feedback of the physicians, 
beginning from the submission of the sample, fol-
lowed by information regarding the symptoms of 
the patient and the clinical picture [9]. 
Some limitations of this study must be acknowl-
edged. Firstly, the presence and nature of symp-
toms of the patients are unknown; additionally, 
due to the inability to access the medical records of 
the individual patients affected, the correlation be-
tween the existence of relevant underlying illness-
es (e.g., Type 2 diabetes, surgical interventions, iat-
rogenic or disease-related immunosuppression) 
and the infection could not be assessed. Further-
more, antimicrobial susceptibility testing of the 
isolated AGNC species was not performed, there-
fore no information is presented regarding the re-
sistance trends in the isolated bacterial strains.
5. Acknowledgements
The authors would like to thank the lab technicians 
of the Institute of Clinical Microbiology for the ex-
cellent laboratory assistance. M.G. was supported 
by the National Youth Excellence Scholarship 
[Grant Number NTP-NTFÖ-18-C-0225] and the ES-
CMID Mentorship and Observership Programme.
6. Competing interests
The authors declare no conflict of interest, mone-
tary or otherwise.
References
1. Tille P. Bailey and Scott’s Diagnostic Microbiology. 
14th ed. St. Louis: Mosby; 2018. 
2. Brazier JS. Veillonella and Other Anaerobic Gram-
Negative Cocci. In: Brian WJ Mahy (ed.): Topley & 
Wilson’s Microbiology and Microbial Infections. 1st 
ed. New Jersey: John Wiley & Sons; 2010. https://doi.
org/10.1002/9780470688618.taw0050
3. Finegold SM. Anaerobic Bacteria in Human Disease. 
New York: Academic Press; 1977.
4. La Scola B, Fournier PE, Raoult D. Burden of emerg-
ing anaerobes in the MALDI-TOF and 16S rRNA gene 
sequencing era. Anaerobe 2011; 17: 106-112. https://doi.
org/10.1016/j.anaerobe.2011.05.010
5. Nagy E, Becker S, Kostrzewa M, Barta N, Urbán E. The 
value of MALDI-TOF MS for the identification of clini-
cally relevant anaerobic bacteria in routine laborato-
ries. J. Med. Microbiol. 2012; 61: 1393-400. https://doi.
org/10.1099/jmm.0.043927-0
6. Siezen RJ, Kleerebezem M. The human gut micro-
biome: Are we our enterotypes? Microb. Biotech-
nol 2011; 4: 550-553. https://doi.org/10.1111/j.1751-
7915.2011.00290.x
7. Bultman SJ. Emerging roles of the microbiome in 
cancer. Carcinogenesis 2014; 35: 249-255. https://doi.
org/10.1093/carcin/bgt392
8. Finegold SM. State of the art; microbiology in health 
and disease. Intestinal bacterial flora in autism. Anaer-
obe 2011; 17: 367-368. https://doi.org/10.1016/j.anaer-
obe.2011.03.007
9. Gajdács M, Spengler, G, Urbán, E. Identification and 
Antimicrobial Susceptibility Testing of Anaerobic 
Bacteria: Rubik’s Cube of Clinical Microbiology? An-
tibiotics 2017; 6: 25. https://doi.org/10.3390/antibiot-
ics6040025
10. Nagy E. Anaerobic Infections Update on Treatment 
Considerations. Drugs 2010; 70: 841-858. https://doi.
org/10.2165/11534490-000000000-00000
11. Urbán E. Five-year retrospective epidemiological sur-
vey of anaerobic bacteraemia in a university hospital 
and rewiew of the literature. Eur. J. Microbiol. Im-
munol. 2012; 2: 140-147. https://doi.org/10.1556/Eu-
JMI.2.2012.2.7
12. Körmöndi S, Terhes G, Pál Z, Varga E, Harmati M, 
Buzás K, Urbán E. Human Pasteurellosis Health Risk 
for Elderly Persons Living with Companion Animals. 
Emerg. Infect. Dis. 2019; 25 (2): 229-235. https://doi.
org/10.3201/eid2502.180641
13. Jousimies-Somer H, Summanen P, Citron DM, Baron 
EJ, Wexler HM, Finegold SM (ed.) Wadsworth-KTL 
Anaerobic Bacteriology Manual, 6th ed. Belmont, CA: 
Star Publishing Company; 2003.
14. Gajdács M. The Concept of an Ideal Antibiotic: Implica-
tions for Drug Design. Molecules 2019; 24: 892. https://
doi.org/10.3390/molecules24050892
15. Gajdács M, Paulik E, Szabó A. [The opinions of com-
munity pharmacists related to antibiotic use and resis-
tance]. Acta Pharm. Hung. 88, 249-252.
16. Veloo AC, de Vries ED, Jean-Pierre H, Justesen US, 
Morris T, Urban E, Wybo I, van Winkelhoff AJ, ENRIA 
workgroup. The optimization and validation of the 
Biotyper MALDI-TOF MS database for the identifica-
tion of Gram-positive anaerobic cocci. Clin. Microbiol. 
Infect. 2016; 22(9): 793-798. https://doi.org/10.1016/j.
cmi.2016.06.016
